Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Days Sales Outstanding : 25.31 (As of Nov. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Days Sales Outstanding?

Cannabis Bioscience International Holdings's average Accounts Receivable for the six months ended in Nov. 2023 was $0.02 Mil. Cannabis Bioscience International Holdings's Revenue for the six months ended in Nov. 2023 was $0.14 Mil. Hence, Cannabis Bioscience International Holdings's Days Sales Outstanding for the six months ended in Nov. 2023 was 25.31.

The historical rank and industry rank for Cannabis Bioscience International Holdings's Days Sales Outstanding or its related term are showing as below:

CBIH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.62 Med: 182.52 Max: 196.93
Current: 50.62

During the past 5 years, Cannabis Bioscience International Holdings's highest Days Sales Outstanding was 196.93. The lowest was 50.62. And the median was 182.52.

CBIH's Days Sales Outstanding is ranked better than
71.47% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.15 vs CBIH: 50.62

Cannabis Bioscience International Holdings's Days Sales Outstanding declined from Nov. 2011 (215.71) to Nov. 2023 (25.31).

Cannabis Bioscience International Holdings Days Sales Outstanding Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Days Sales Outstanding Chart

Cannabis Bioscience International Holdings Annual Data

Trend

Dec06

Dec07

May09

May10

May11

Days Sales Outstanding

144.51

196.93

182.52

Cannabis Bioscience International Holdings Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	May09	Nov09	May10	Nov10	May11	Nov11	Nov22	Nov23
Days Sales Outstanding	Get a 7-Day Free Trial							232.78	243.16	215.71	39,590.00	25.31

Competitive Comparison of Cannabis Bioscience International Holdings's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Bioscience International Holdings's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Days Sales Outstanding falls into.

Cannabis Bioscience International Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cannabis Bioscience International Holdings's Days Sales Outstanding for the fiscal year that ended in May. 2011 is calculated as

	Days Sales Outstanding (A: May. 2011 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: May. 2010 )	+	Accounts Receivable (A: May. 2011 ))	/	count )	/	Revenue (A: May. 2011 )	*	Days in Period
=	( (53.412	+	30.058)	/	2 )	/	83.461	*	365
=	41.735					/	83.461	*	365
=	182.52

Cannabis Bioscience International Holdings's Days Sales Outstanding for the quarter that ended in Nov. 2023 is calculated as:

	Days Sales Outstanding (Q: Nov. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Nov. 2022 )	+	Accounts Receivable (A: Nov. 2023 ))	/	count )	/	Revenue (A: Nov. 2023 )	*	Days in Period
=	( (0	+	0.019)	/	1 )	/	0.137	*	365 / 2
=	0.019					/	0.137	*	365 / 2
=	25.31

Cannabis Bioscience International Holdings (OTCPK:CBIH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Cannabis Bioscience International Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036

Website

https://www.cbih.net

Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.